Alpine Global Management’s Q32 Bio QTTB Stock Holding History

Alpine Global Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-684	Closed	-$255K	–	458
2019 Q4	$255K	Buy	+684	New	+$196K	0.05%	296

Other funds holding QTTB

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alpine Global Management's QTTB Position: Q1 2020 in Review

Alpine Global Management sold out of Q32 Bio (QTTB) in Q1 2020, closing a stake of 684 shares — an estimated $255K sold.

Alpine Global Management first reported a position in QTTB in Q4 2019 and held it in 1 quarter. The position peaked at $255K in Q4 2019. 91 funds tracked by Wall St. Rank hold QTTB as of Q1 2020.

Alpine Global Management reported no remaining Q32 Bio position as of Q1 2020 after selling out during the quarter.
Alpine Global Management sold 684 Q32 Bio shares in Q1 2020, an estimated $255K.
Alpine Global Management first reported a position in Q32 Bio in Q4 2019 and held it in 1 quarter.
Alpine Global Management's Q32 Bio position peaked at $255K in Q4 2019.
91 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2020.

Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.